Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
NCT: NCT03492944 · COMPLETED
Brief Summary
The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease
Frequently Asked Questions
What is Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason?
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason is a clinical trial registered under NCT03492944. Current status: COMPLETED.
What is the status of NCT03492944?
The current status of NCT03492944 (Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason) is: COMPLETED.
When did Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason start?
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason started on 2020-03-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.